MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH BRIEF – June 13, 2025
One Big Thing Regulators, providers and investors just treated AI‑imaging as “business‑critical infrastructure.” FDA’s CADx‑to‑Class II order, Viz.ai’s third neuro‑module clearance and a bipartisan push to pay for AI all landed in the same week—compressing regulatory, clinical and economic tail‑winds into a single market‑moving burst. Key Takeaways Signal‑to‑Noise Heat Bar Where last week’s 10 macro signals rank Signal Pulse Heatmap Six events that actually […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH BRIEF – May 30, 2025
One Big Thing The FDA’s decision to roll its in-house generative-AI suite across all centers by 30 June collides with Hyperfine’s tenth-gen Optive AI clearance: regulatory throughput and bedside image quality are now improving in lock-step, compressing go-to-market timelines and expanding clinical reach simultaneously. Key Takeaways Signal Pulse Heatmap Event Score Marketstrat Takeaway FDA AI […]
MARKINTEL PULSE – WEEKLY MEDTECH, IMAGING & DIGITAL HEALTH BRIEF – May 23, 2025
One Big Thing AI-first imaging is sprinting ahead—just as tariff headwinds force OEMs to redraw global supply chains. This week’s triple-play of U.S. AI clearances (fetal heart ultrasound, spine MRI, and interventional CBCT) landed within 72 hours, underscoring the FDA’s momentum on imaging AI. Meanwhile, new tariff disclosures exceed US $2 B for the top […]
